Cargando…

Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder

Objectives. To evaluate whether there are any demographic or urodynamic differences in patients with idiopathic overactive bladder (I-OAB) that respond and do not respond to intradetrusor injections of botulinum toxin-A (BTX-A). Methods. This represents a secondary analysis of data collected from an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Brian L., Caruso, Daniel J., Kanagarajah, Prashanth, Gousse, Angelo E.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739422/
https://www.ncbi.nlm.nih.gov/pubmed/19746201
http://dx.doi.org/10.1155/2009/328364
_version_ 1782171581958586368
author Cohen, Brian L.
Caruso, Daniel J.
Kanagarajah, Prashanth
Gousse, Angelo E.
author_facet Cohen, Brian L.
Caruso, Daniel J.
Kanagarajah, Prashanth
Gousse, Angelo E.
author_sort Cohen, Brian L.
collection PubMed
description Objectives. To evaluate whether there are any demographic or urodynamic differences in patients with idiopathic overactive bladder (I-OAB) that respond and do not respond to intradetrusor injections of botulinum toxin-A (BTX-A). Methods. This represents a secondary analysis of data collected from an investigator initiated randomized trial designed to evaluate clinical differences in outcomes for 100 versus 150 U BTX-A in patients with I-OAB. Preinjection demographic and urodynamic data were collected. Patients were evaluated 12 weeks after injection and were determined to be responders or nonresponders as defined by our criteria. Statistical comparisons were made between groups. Results. In patients with overactive bladder without incontinence (OAB-Dry), there were no variables that could be used to predict response to BTX-A. On univariate analysis, younger patients with overactive bladder with incontinence (OAB-Wet) were more likely to respond to BTX-A than older patients. However, this relationship was no longer statistically significant on multivariate analysis. Conclusions. We were unable to identify any preinjection demographic or urodynamic parameters that could aid in predicting which patients will achieve clinical response to BTX-A. Future studies are necessary to further evaluate this question.
format Text
id pubmed-2739422
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-27394222009-09-09 Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder Cohen, Brian L. Caruso, Daniel J. Kanagarajah, Prashanth Gousse, Angelo E. Adv Urol Clinical Study Objectives. To evaluate whether there are any demographic or urodynamic differences in patients with idiopathic overactive bladder (I-OAB) that respond and do not respond to intradetrusor injections of botulinum toxin-A (BTX-A). Methods. This represents a secondary analysis of data collected from an investigator initiated randomized trial designed to evaluate clinical differences in outcomes for 100 versus 150 U BTX-A in patients with I-OAB. Preinjection demographic and urodynamic data were collected. Patients were evaluated 12 weeks after injection and were determined to be responders or nonresponders as defined by our criteria. Statistical comparisons were made between groups. Results. In patients with overactive bladder without incontinence (OAB-Dry), there were no variables that could be used to predict response to BTX-A. On univariate analysis, younger patients with overactive bladder with incontinence (OAB-Wet) were more likely to respond to BTX-A than older patients. However, this relationship was no longer statistically significant on multivariate analysis. Conclusions. We were unable to identify any preinjection demographic or urodynamic parameters that could aid in predicting which patients will achieve clinical response to BTX-A. Future studies are necessary to further evaluate this question. Hindawi Publishing Corporation 2009 2009-09-08 /pmc/articles/PMC2739422/ /pubmed/19746201 http://dx.doi.org/10.1155/2009/328364 Text en Copyright © 2009 Brian L. Cohen et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Cohen, Brian L.
Caruso, Daniel J.
Kanagarajah, Prashanth
Gousse, Angelo E.
Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder
title Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder
title_full Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder
title_fullStr Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder
title_full_unstemmed Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder
title_short Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder
title_sort predictors of response to intradetrusor botulinum toxin-a injections in patients with idiopathic overactive bladder
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739422/
https://www.ncbi.nlm.nih.gov/pubmed/19746201
http://dx.doi.org/10.1155/2009/328364
work_keys_str_mv AT cohenbrianl predictorsofresponsetointradetrusorbotulinumtoxinainjectionsinpatientswithidiopathicoveractivebladder
AT carusodanielj predictorsofresponsetointradetrusorbotulinumtoxinainjectionsinpatientswithidiopathicoveractivebladder
AT kanagarajahprashanth predictorsofresponsetointradetrusorbotulinumtoxinainjectionsinpatientswithidiopathicoveractivebladder
AT gousseangeloe predictorsofresponsetointradetrusorbotulinumtoxinainjectionsinpatientswithidiopathicoveractivebladder